• TRM (USD/COP)COP 3,235.59 +1.65% +COP 52.60Colombia's official exchange rate (Financial Superintendence), valid Nov 4 to Nov 4
  • EuroCOP 3,617.08 +1.72% +COP 61.02Reference: TRM crossed with the European Central Bank rate of Nov 3; not the market quote
  • Mexican pesoCOP 173.98 +3.35% +COP 5.64Reference: TRM crossed with the European Central Bank rate of Nov 3; not the market quote

Moderna and Merck shares slump after melanoma vaccine data leaks

FinanceInternationalEL PAÍS40 s readAI summary
Image: EL PAÍS

Moderna and Merck shares fell after data on their personalized melanoma vaccine disappointed Wall Street. Moderna dropped as much as 26% on Thursday, a record intraday decline, while Merck slipped 3.9%. The data leaked ahead of schedule and were later confirmed by Merck: the vaccine reduced the risk of cancer recurrence by 42% and the risk of metastasis by 38%. The results were due to be presented on Saturday at the European Society for Medical Oncology meeting in Madrid.

In 40 seconds

  • Moderna fell as much as 26% intraday, a record, and Merck slipped 3.9% after the data emerged.
  • The vaccine reduced the risk of cancer recurrence by 42% and the risk of distant spread by 38%.
  • The data leaked on social media platform X ahead of schedule and Merck later confirmed them.
Read the full story at EL PAÍS

IASummary generated by artificial intelligence from a story by EL PAÍS. It may contain errors: the original source prevails.

Comments

Be respectful. Comments reported by several people are hidden until a moderator reviews them.

You do not need an account to read, only to comment. Sign in with a code sent to your email or with your Google account. We only show the name you choose, never your email.

    Keep reading